Ignite Creation Date:
2025-12-24 @ 1:31 PM
Ignite Modification Date:
2026-02-26 @ 7:24 PM
Study NCT ID:
NCT05642195
Status:
SUSPENDED
Last Update Posted:
2025-12-24
First Post:
2022-12-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluation of a Cancer Lysate Vaccine and Montanide (Registered Trademark) ISA-51 VG With or Without the IL-15 Super-Agonist N-803 as Adjuvant Therapy for PD-L1 Negative Non-Small Cell Lung Cancer
Sponsor:
National Cancer Institute (NCI)
Organization:
Conditions & Keywords Data
Conditions:
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Immunotherapy | View |
| None | NSCLC | View |
| None | H1299 Cell Lysates | View |
| None | No Clinical Evidence Of Active Disease (Ned) | View |
| None | Minimal Residual Disease (Mrd) | View |
| None | Disease-Free Survival (Dfs) | View |
| None | Ct-X Antigens | View |
| None | Autosomal Ct Antigens | View |
| None | Cell Mediated Response | View |